Cascador Health Company Profile

Background

Founded in 2021, Cascador Health is a Belgian company dedicated to unlocking the potential of real-world medical data to enhance healthcare outcomes. By providing structured, validated, and anonymized real-world data (RWD), Cascador Health enables healthcare providers and the life sciences industry to make informed decisions, improve therapies, and validate treatment performances. The company's mission is to bridge the gap between data sources and users, ensuring that valuable medical information is accessible for secondary use while maintaining strict compliance with privacy and security standards.

Key Strategic Focus

Cascador Health's strategic focus centers on facilitating secure and transparent access to medical data for secondary use. The company specializes in:

• Market Access: Providing insights into market trends, disease prevalence, and therapy adoption to assist in product planning and pricing strategies.

• Clinical Evidence: Conducting robust studies to generate real-world evidence, supporting clinical decisions and policy-making.

• Therapy Adoption: Identifying barriers to new therapy adoption and offering actionable insights to bridge the evidence-practice gap.

By leveraging advanced analytical tools and collaborating with key opinion leaders, Cascador Health aims to enhance the efficiency of research processes and contribute to better patient outcomes.

Financials and Funding

Since its inception, Cascador Health has secured significant funding to support its growth and development:

• Series A Funding (March 2022): The company raised €3.4 million (approximately $3.7 million) in a Series A funding round. Investors included Belgian venture capital firms Qbic, Volta Ventures, and Theodorus, as well as the Swiss healthcare provider Hirslanden AG. The capital is intended for further validation of the data platform and European expansion.

Pipeline Development

Cascador Health has developed specialized programs to generate real-world evidence in specific therapeutic areas:

• CHRINOSOR (Chronic Rhinosinusitis Outcome Registry): This program focuses on patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Collaborating with pharmaceutical sponsors and top clinical centers, CHRINOSOR aims to deliver real-world evidence on therapy efficacy, eligibility, and prescription behaviors. The program has resulted in multiple scientific publications presented at leading congresses.

Technological Platform and Innovation

Cascador Health distinguishes itself through its proprietary technological platforms and innovative methodologies:

• Cascador Edge/Merge: A digital platform that collects, anonymizes, and analyzes real-world data from healthcare providers across Europe. It ensures secure and compliant data access, facilitating the generation of real-world evidence.

• Federated Data Architecture: This approach allows data analysis to occur within the healthcare providers' infrastructure, ensuring that raw data remains on their servers. Only anonymized results are shared with external users, maintaining data privacy and security.

Leadership Team

Cascador Health is led by a team of experienced professionals:

• Philip Taillieu: Co-Founder & Chief Executive Officer. Formerly co-founder and co-CEO of Be-Mobile NV, a company acquired by Proximus.

• Ludo Ooms: Co-Founder & Chief Financial Officer.

• Sven Van Segbroeck: Co-Founder & Chief Technology Officer.

• Laurent Laffineur: Head of Strategic Partnerships.

• Gert Mariën: Head of Sales.

• Joost de Kinderen: Head of Product & Insights Lab.

• Joëlle Champagne: Business Development Manager DACH & BeNeLux.

• Giulia Bettio: Senior Consultant.

• Maarten Vanden Branden: Software Engineer.

• Ben De Weerdt: Software Engineer.

• Jan Parasote: Software Engineer.

The Board of Directors includes:

• Dr. Abed Hamoud: Chairman of the Board of Directors & Managing Director Alant Health Sarl.

• Jan Cools: CEO & Founder Be-Mobile Group.

• Koen De Waele: Venture Partner Volta Ventures.

• Steven Leuridan PhD CFA: Partner PhD QBIC Fund | Venture Capital.

• Luc Dochez: Managing Partner, DROIA Genetic Disease Fund.

• Philip Taillieu: CEO.

Competitor Profile

Market Insights and Dynamics

The healthcare data analytics market is experiencing significant growth, driven by the increasing demand for data-driven insights to improve patient outcomes, optimize healthcare processes, and support clinical research. The integration of real-world data into healthcare decision-making is becoming a critical component for stakeholders across the industry.

Competitor Analysis

Cascador Health operates in a competitive landscape with several notable companies:

• HealthVerity: Founded in 2015, HealthVerity is a privately held company with 100-250 employees and has raised $145.9 million in funding. It focuses on providing data solutions for healthcare and life sciences.